AI assistant
Medicover — Board/Management Information 2018
Sep 26, 2018
2943_rns_2018-09-26_56d6bc3e-1024-49f9-9a51-e4093c269d58.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Press Release Stockholm 26 September 2018
MEDICOVER'S NOMINATION COMMITTEE FOR THE ANNUAL GENERAL MEETING 2019
Medicover publishes the nomination committee's composition for the annual general meeting in 2019.
The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on 26 April 2018, consists of:
- Fredrik Stenmo, representing Celox Holding AB and the af Jochnick family's total shareholding
- Per Colleen, Fjärde AP-Fonden
- Erik Malmberg, TVF TopCo Limited
The Board of Medicover AB (publ)
For more information, please visit:
https://investors.medicover.com/
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting on 3 May 2019 can do so by e-mail to [email protected] or:
Medicover AB Att: Nomination Committee/General Legal Counsel Box 55720 114 83 Stockholm Sweden
Proposals should be submitted to the nomination committee before 15 March 2019.
For further information, please contact:
Paula Treutiger, Director Corporate Communication & Investor Relations
Phone: +46 73 366 65 99 [email protected]
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenue around €580 million and 15,900 employees. For more information, go to www.medicover.com